Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $544.90 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Smith+Nephew, Inc. | $381.06 | 12 | $0 (2020) |
| Lilly USA, LLC | $27.19 | 2 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.72 | 1 | $0 (2017) |
| Amgen Inc. | $20.13 | 1 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $16.61 | 1 | $0 (2017) |
| Genentech USA, Inc. | $15.30 | 1 | $0 (2018) |
| Allergan Inc. | $14.79 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $14.23 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $13.33 | 1 | $0 (2017) |
| Metuchen Pharmaceuticals | $10.89 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $181.00 | 7 | Smith+Nephew, Inc. ($181.00) |
| 2019 | $199.06 | 5 | Smith+Nephew, Inc. ($188.17) |
| 2018 | $46.08 | 3 | Amgen Inc. ($20.13) |
| 2017 | $118.76 | 8 | Lilly USA, LLC ($27.19) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/10/2020 | Smith+Nephew, Inc. | GRAFIX PL (Biological) | Food and Beverage | In-kind items and services | $31.71 | General |
| Category: Other Advanced Wound Management | ||||||
| 06/25/2020 | Smith+Nephew, Inc. | GRAFIX PL (Biological) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Other Advanced Wound Management | ||||||
| 05/08/2020 | Smith+Nephew, Inc. | Santyl (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Pharma Product | ||||||
| 03/04/2020 | Smith+Nephew, Inc. | REGRANEX (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Pharma Product | ||||||
| 02/28/2020 | Smith+Nephew, Inc. | GRAFIX PL (Biological) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Other Advanced Wound Management | ||||||
| 02/26/2020 | Smith+Nephew, Inc. | Santyl (Drug) | Food and Beverage | In-kind items and services | $45.91 | General |
| Category: Pharma Product | ||||||
| 01/09/2020 | Smith+Nephew, Inc. | GRAFIX PL (Biological) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Other Advanced Wound Management | ||||||
| 11/12/2019 | Smith+Nephew, Inc. | Grafix PL PRIME (Biological) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Other Advanced Wound Management | ||||||
| 10/15/2019 | Metuchen Pharmaceuticals | Stendra (Drug) | Food and Beverage | Cash or cash equivalent | $10.89 | General |
| Category: Erectile Dysfunction | ||||||
| 10/05/2019 | Smith+Nephew, Inc. | Grafix PL PRIME (Biological) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Other Advanced Wound Management | ||||||
| 08/27/2019 | Smith+Nephew, Inc. | Grafix PL PRIME (Biological) | Food and Beverage | In-kind items and services | $131.25 | General |
| Category: Other Advanced Wound Management | ||||||
| 06/14/2019 | Smith+Nephew, Inc. | Stravix (Biological), Grafix, GrafixPL | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: Other Advanced Wound Management | ||||||
| 12/14/2018 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Virology & Specialty Care | ||||||
| 05/18/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $10.65 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/04/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Cardiology | ||||||
| 08/15/2017 | Smith & Nephew, Inc. | Santyl (Drug), Regranex | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: Pharma Product | ||||||
| 08/11/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: DIABETES | ||||||
| 08/04/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/26/2017 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/13/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/16/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: DIABETES | ||||||
| 03/16/2017 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Diabetes | ||||||
| 02/09/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 8 | 361 | 481 | $99,858 | $28,614 |
| 2020 | 10 | 436 | 650 | $68,207 | $35,618 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 74 | 74 | $25,086 | $9,971 | 39.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 91 | 114 | $36,822 | $9,519 | 25.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 50 | 74 | $16,132 | $4,583 | 28.4% |
| 97597 | Removal of tissue from wounds per session, first 20 sq cms or less | Facility | 2021 | 17 | 69 | $15,663 | $1,975 | 12.6% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 14 | 14 | $2,856 | $1,757 | 61.5% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 24 | 33 | $1,419 | $320.43 | 22.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 17 | 17 | $1,020 | $294.83 | 28.9% |
| 81003 | Automated urinalysis test | Office | 2021 | 74 | 86 | $860.00 | $193.50 | 22.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 80 | 80 | $12,660 | $9,017 | 71.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 83 | 84 | $17,490 | $8,077 | 46.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 61 | 108 | $15,519 | $7,785 | 50.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 32 | 115 | $10,405 | $4,518 | 43.4% |
| 97597 | Removal of tissue from wounds per session | Facility | 2020 | 26 | 103 | $5,295 | $2,370 | 44.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 19 | 19 | $3,790 | $1,917 | 50.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 21 | 21 | $2,521 | $1,520 | 60.3% |
| 81002 | Urinalysis, manual test | Office | 2020 | 75 | 81 | $276.21 | $274.46 | 99.4% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2020 | 25 | 25 | $112.00 | $108.78 | 97.1% |
| 81003 | Automated urinalysis test | Office | 2020 | 14 | 14 | $140.00 | $31.50 | 22.5% |
About Dr. Louis Nardizzi, MD
Dr. Louis Nardizzi, MD is a Internal Medicine healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972554947.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Louis Nardizzi, MD has received a total of $544.90 in payments from pharmaceutical and medical device companies, with $181.00 received in 2020. These payments were reported across 23 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($544.90).
As a Medicare-enrolled provider, Nardizzi has provided services to 797 Medicare beneficiaries, totaling 1,131 services with total Medicare billing of $64,232. Data is available for 2 years (2020–2021), covering 18 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Dallas, TX
- Active Since 05/15/2006
- Last Updated 11/16/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1972554947
Products in Payments
- Grafix PL PRIME (Biological) $159.40
- GRAFIX PL (Biological) $99.37
- Santyl (Drug) $79.29
- JARDIANCE (Drug) $36.83
- Stravix (Biological) $28.77
- Repatha (Biological) $20.13
- TOUJEO (Drug) $16.61
- Xofluza (Drug) $15.30
- BYSTOLIC (Drug) $14.79
- REGRANEX (Drug) $14.23
- XARELTO (Drug) $14.23
- FARXIGA (Drug) $13.33
- TRULICITY (Drug) $11.08
- Stendra (Drug) $10.89
- JANUVIA (Drug) $10.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Dallas
Andrew Whiteley
Internal Medicine — Payments: $1.7M
Biff Palmer, Md, MD
Internal Medicine — Payments: $980,569
Dr. Robert Gottlieb, M.d. Ph.d, M.D. PH.D
Internal Medicine — Payments: $832,284
Dr. Ronan Kelly, Md, MD
Internal Medicine — Payments: $813,092
Dr. Gates Colbert, M.d, M.D
Internal Medicine — Payments: $801,349
Dr. Zoran Kurepa, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $743,379